KELSEE cpr ret 2 mg/ 0.02 mg 28 pce

7680696160016 CH-69616 G03AA16 09.02.1.

Active substances:

Dienogestum

No images available

Details

Product number
6961601
CPT
-
Packaging group
1 x 28
Unit
Tablette(n)
Composition
I) weisse Retardtablette: dienogestum 2 mg, ethinylestradiolum 0.02 mg, lactosum monohydricum 19.48 mg, hypromellosum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso. II) runde, grüne, Placebotablette: lactosum monohydricum 55.5 mg, maydis amylum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, triacetinum, polysorbatum 80, E 171, E 132, E 172 (flavum), pro compresso.

Articles (1)

Kelsee Dienogest 2 mg/ 0.02 mg Ethinylestradiol, Retardtabletten
Tabletten
1 x 28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/03/2026
Professional SmPC
Français
11/03/2026
Professional SmPC
Italien
11/03/2026
Patient information leaflet
Allemand
12/12/2025
Patient information leaflet
Français
12/12/2025
Patient information leaflet
Italien
12/12/2025

Detailed composition

Substance Quantity Type Category
lactosum monohydricum
55.5 MG Substance HBESI
dienogestum
2.0 MG Substance Wirkstoff (Principe actif)
maydis amylum
- Substance HNIDK
ethinylestradiolum
0.02 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
19.48 MG Substance HBESI
povidonum K 30
- Substance HNIDK
hypromellosum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
povidonum K 30
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
hypromellosum
- Substance HNIDK
triacetinum
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
macrogolum 3350
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
talcum
- Substance HNIDK

Authorization holder

Exeltis Suisse SA

1228 Plan-Ies-Ouates

Authorization information

Swissmedic authorization number
69616
Drug name
Kelsee, Retardtabletten
Galenic form
RETT
ATC Code
G03AA16
Authorization status
Z
Dispensation category
B
First authorization
13/08/2025
Authorization expiration date
12/08/2030
IT number
09.02.1.
Domain
Human medicine
Field of application
Hormonale Kontrazeption

Packaging details

Description (FR)
KELSEE cpr ret 2 mg/ 0.02 mg 28 pce
Description (DE)
KELSEE Ret Tabl 2 mg/ 0.02 mg 28 Stk
Market launch
27/01/2026
Narcotic (BTM)
No

Other packaging sizes

KELSEE cpr ret 2 mg/ 0.02 mg 3 x 28 pce
3 x 28 TABL
GTIN: 7680696160023
View
Buy us a coffee Explore the data